U-937 人組織細(xì)胞**瘤細(xì)胞

]資料

點(diǎn)擊看大圖

如果您對(duì)該產(chǎn)品感興趣的話,可以

產(chǎn)品名稱: U-937 人組織細(xì)胞**瘤細(xì)胞
產(chǎn)品型號(hào): CRL-1593.2
產(chǎn)品廠商: 美國標(biāo)準(zhǔn)生物品收藏中心（ATCC）
產(chǎn)品文檔: 無相關(guān)文檔

簡(jiǎn)單介紹

CRL-1593.2 U-937 人組織細(xì)胞**瘤細(xì)胞，原代細(xì)胞|細(xì)胞系|細(xì)胞株|菌種；細(xì)胞庫管理規(guī)范，提供的細(xì)胞株背景清楚，提供參考文獻(xiàn)和培養(yǎng)條件！

U-937 人組織細(xì)胞**瘤細(xì)胞的詳細(xì)介紹

CRL-1593.2 U-937 人組織細(xì)胞**瘤細(xì)胞

ATCC^® Number:

CRL-1593.2?

Price:

Designations:	U-937
Depositors:	H Koren
Biosafety Level:	1
Shipped:	frozen
Medium & Serum:	See Propagation
Growth Properties:	suspension
Organism:	Homo sapiens (human)
Morphology:	monocyte
Source:	Disease: histiocytic lymphoma
Cellular Products:	lysozyme; beta-2-microglobulin (beta 2 microglobulin); tumor necrosis factor (TNF), also known as tumor necrosis factor alpha (TNF-alpha, TNF alpha), after stimulation with phorbol myristic acid (PMA)
Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Restrictions:	The original U-937 cell line was established by Dr. K. Nilsson's laboratory in 1974 and he has requested the following: (1) In all papers reporting any use of this cell line or any derivatives thereof a direct reference should be made to Sundstrom and Nilsson (Int. J. Cancer 17: 565-577, 1976). (2) Any proposed commercial use of the cells should be negotiated with Professor Kenneth Nilsson, Rudbeck Laboratory, SE-751 85 Uppsala, Sweden. (3) No distribution of any of the cells or sublines derived therefrom should be made to third parties; (4) The cells should be used for non-clinical, non-commercial research only.
Isolation:	Isolation date: 1974
Applications:	transfection host (Roche FuGENE® Transfection Reagents Nucleofection technology from Lonza)
Receptors:	complement (C3)
DNA Profile (STR):	Amelogenin: X CSF1PO: 12 D13S317: 10,12 D16S539: 12 D5S818: 12 D7S820: 9,11 THO1: 9.3 TPOX: 8,11 vWA: 15
Age:	37 years
Gender:	male
Ethnicity:	Caucasian
Comments:	The U-937 cell line was derived by Sundstrom and Nilsson in 1974 from malignant cells obtained from the pleural effusion of a patient with histiocytic lymphoma. Studies since 1979 have shown that U-937 cells can be induced to terminal monocytic differentiation by supernatants from human mixed lymphocyte cultures, phorbol esters, vitamin D3, gamma interferon, tumor necrosis factor (TNF) and, retinoic acid. The cells are negative for immunoglobulin production and Epstein-Barr virus expression. The cells express the Fas antigen, and are sensitive to TNF and anti-Fas antibodies. In 1994, PCR and cytogenetic analyses showed that a number of stocks of U-937 were contaminated with the human myeloid leukemia cell line, K-562. In the earliest stocks available, the level of contamination was 0.6%. [40484] Distribution was discontinued in March 1994, except if required for patent purposes. Anyone who wishes to receive a sample of this original material should contact the Head of the ATCC Patent Depository. A stock of CRL-1593 found to be free of K-562 was propagated continuously for 8 weeks and tested weekly by PCR. Distribution and seed stocks give DNA profiles characteristic of U-937 only. Such preparations are now offered as authentic U-937 (ATCC CRL-1593.2) and are believed to be free of second subpopulations.
Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Atmosphere: air, 95%; carbon dioxide (CO2), 5% Temperature: 37.0°C
Subculturing:	Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 10(5) viable cells/ml. Interval: Maintain cell density between 1 X 10(5) and 2 X 10(6) viable cells/ml. Medium Renewal: Add fresh medium every 3 to 4 days (depending on cell density)
Preservation:	Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO Storage temperature: liquid nitrogen vapor phase
Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001 recommended serum:ATCC 30-2020
References:	1080: Ralph P, et al. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J. Exp. Med. 143: 1528-1533, 1976. PubMed: 1083890 21866: . Gene expression during normal and malignant differentiation. London: Academic Press; 1985. 21876: . International symposium on new trends in human immunology and cancer immunotherapy. Paris: Doin Editeurs; 1980. 22906: Koren HS, et al. In vitro activation of a human macrophage-like cell line. Nature 279: 328-331, 1979. PubMed: 450085 22912: Gidlund M, et al. Natural killer cells kill tumour cells at a given stage of differentiation. Nature 292: 848-850, 1981. PubMed: 7266653 23049: Olsson I, et al. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. Cancer Res. 43: 5862-5867, 1983. PubMed: 6315218 23103: Morimoto H, et al. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res. 53: 2591-2596, 1993. PubMed: 7684321

產(chǎn)品留言

標(biāo)題

聯(lián)系人

聯(lián)系電話

內(nèi)容

驗(yàn)證碼

點(diǎn)擊換一張

注：1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請(qǐng)您留下您的詳細(xì)聯(lián)系方式!

相關(guān)產(chǎn)品

3T3D 人骨髓瘤細(xì)胞 3T3D 人骨髓瘤細(xì)胞

HTB-120 NCI-H128 人肺小細(xì)胞肺癌細(xì)胞 HTB 120 NCI H128

HTB-119 NCI-H69 [H69]人肺小細(xì)胞肺癌細(xì)胞 HTB-119

HS77 人肺小細(xì)胞肺癌細(xì)胞 HS77

D6 人肺腺癌細(xì)胞 D6

聯(lián)系我們



 	電      話：021-35080510

 手       機(jī): 15000266580（微信同步）

 菌種Q Q ： 316826860

 細(xì)胞Q Q ：1784382136

  
 

 
 	菌種Q Q:1623059823 
 
 Email：xiangfbio@163.com

產(chǎn)品搜索

細(xì)胞系，ATCC細(xì)胞，ATCC菌種，細(xì)胞系目錄，ATCC，鼠傷寒沙門氏菌，atcc細(xì)胞庫，人**瘤細(xì)胞，人食管癌細(xì)胞，ATCC 19404，ATCC 25922，ATCC 19146，微生物菌種，細(xì)胞株，標(biāo)準(zhǔn)菌株，ATCC中國，atcc上海代理，CMCC 菌株，ATCC菌株，細(xì)胞目錄，質(zhì)控菌株，腫瘤細(xì)胞株，乳腺癌細(xì)胞系，人肝癌細(xì)胞系

產(chǎn)品目錄

Copyright? 2003-2025 上海復(fù)祥生物科技有限公司版權(quán)所有電話：021-35080510
傳真：021-35080520 地址：上海市虹口區(qū)赤峰路630號(hào)南雁大廈1901室郵編：滬ICP備10013034號(hào)-3

最好免费观看高清在线,中文字幕在线日亚洲9,亚洲情+欧美,亚洲欧美丝袜精品久久,亚洲国产另类久久久精品黑人

U-937 人組織細(xì)胞**瘤細(xì)胞

CRL-1593.2 U-937 人組織細(xì)胞**瘤細(xì)胞，原代細(xì)胞|細(xì)胞系|細(xì)胞株|菌種；細(xì)胞庫管理規(guī)范，提供的細(xì)胞株背景清楚，提供參考文獻(xiàn)和培養(yǎng)條件！

CRL-1593.2 U-937 人組織細(xì)胞**瘤細(xì)胞，原代細(xì)胞|細(xì)胞系|細(xì)胞株|菌種；細(xì)胞庫管理規(guī)范，提供的細(xì)胞株背景清楚，提供參考文獻(xiàn)和培養(yǎng)條件！